Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flagellin is the primary structural protein of the bacterial flagellum in Salmonella enterica serovar Paratyphi A, primarily encoded by the fliC gene (UniProt, 2024). It serves a dual role in pathogenesis: providing the motility required for the bacteria to reach and invade host intestinal epithelial cells and acting as a potent pathogen-associated molecular pattern (PAMP) (Infection and Immunity, 2015). Upon infection, flagellin is recognized by the host's Toll-like receptor 5 (TLR5), which triggers the activation of pro-inflammatory signaling pathways and the innate immune system (NIH, 2004). In Salmonella Paratyphi A, flagellin also plays a regulatory role in the expression of the Salmonella pathogenicity island 1 (SPI-1), which is essential for host cell invasion (ASM, 2015). Due to its high immunogenicity and surface exposure, flagellin is a major target for the development of vaccines against paratyphoid fever, a significant cause of enteric fever globally (MDPI, 2024). Experimental vaccines, such as the live-attenuated strain CVD 1902, utilize flagellin as a key antigen to elicit protective IgG and IgA antibody responses (NEJM, 2025). The interaction between flagellin and TLR5 is also being explored for its potential as a vaccine adjuvant to enhance the overall immune response (NIH, 2011). While Salmonella Paratyphi A is typically monophasic, the variation of flagellin in other serovars is a known mechanism for immune evasion (MDPI, 2024).
Vaccine antigen that induces protective humoral (IgG, IgA) and cellular immune responses; also acts as a TLR5 agonist to stimulate innate immunity (NEJM, 2025; NIH, 2011).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flagellin (FliC) of Salmonella enterica serovar Paratyphi A (FliC).